Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development

Journal of Clinical Investigation

Volumn 122, Issue 2, 2012, Pages 497-506

  Maegdefessel, Lars ^a   Azuma, Junya ^a   Toh, Ryuji ^a   Merk, Denis R ^a   Deng, Alicia ^a   Chin, Jocelyn T ^a   Raaz, Uwe ^a   Schoelmerich, Anke M ^a   Raiesdana, Azad ^a   Leeper, Nicholas J ^a   McConnell, Michael V ^a   Dalman, Ronald L ^a   Spin, Joshua M ^a   Tsao, Philip S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; COLLAGEN 1 ALPHA 1; COLLAGEN 3 ALPHA 1; COLLAGEN 5 ALPHA 1; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; ELASTIN; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA; MICRORNA 29B; NUCLEIC ACID; PANCREATIC ELASTASE; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA RUPTURE; AORTA WALL; ARTICLE; CELL CULTURE; DISEASE COURSE; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; UPREGULATION;

ADOLESCENT; AGED; ANEURYSM, RUPTURED; ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; COLLAGEN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELASTIN; GENE EXPRESSION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MIDDLE AGED; PANCREATIC ELASTASE; PROTEIN ISOFORMS; SWINE; YOUNG ADULT;

EID: 84856552278     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI61598     Document Type: Article

References (32)

1. Weintraub NL. Understanding abdominal aortic aneurysm. N Engl J Med. 2009;361(11):1114-1116.
2. Creager MA, et al. Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapy. Circulation. 2004;109(21):2634- 2642. (Pubitemid 38720568)
3. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004;110(1):16-21. (Pubitemid 38880128)
4. Thompson RW, Liao S, Curci JA. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis. 1997;8(10):623-631. (Pubitemid 28029588)
5. Zhang C. MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics. 2008;33(2):139-147. (Pubitemid 351629522)
6. Roderburg C, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53(1):209-218.
7. Qin W, et al. TGF-{beta}/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29. J Am Soc Nephrol. 2011;22(8):1462-1474.
8. van Rooij E, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A. 2008;105(35):13027-13032.
9. De Paepe A, Nuytinck L, Hausser I, Anton-Lamprecht I, Naeyaert JM. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet. 1997;60(3):547-554. (Pubitemid 27097602)
10. Rahkonen O, et al. Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture. Circ Res. 2004;94(1):83-90. (Pubitemid 38064102)
11. Menashi S, Campa JS, Greenhalgh RM, Powell JT. Collagen in abdominal aortic aneurysm: typing, content, and degradation. J Vasc Surg. 1987;6(6):578-582. (Pubitemid 18017998)
12. Rizzo RJ, et al. Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg. 1989;10(4):365-373. (Pubitemid 19248900)
13. Chen KC, et al. OxLDL upregulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 2011;25(5):1718-1728.
14. Thompson RW, Curci JA, Ennis TL, Mao D, Pagano MB, Pham CT. Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann N Y Acad Sci. 2006;1085:59-73. (Pubitemid 47096570)
15. Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004;24(3):429-434. (Pubitemid 38326134)
16. Liao M, et al. A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to thoracic aortic dissection pathogenesis. J Vasc Surg. 2011;53(5):1341-1349.
17. Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature. 2011;473(7347):308-316.
18. Holm TM, et al. Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science. 2011;332(6027):358-361.
19. Regalado ES, et al. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res. 2011;109(6):680-686.
20. Wang Y, et al. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest. 2010;120(2):422-432.
21. Frutkin AD, et al. TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2009;29(9):1251-1257.
22. Dai J, et al. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005;112(7):1008-1015. (Pubitemid 41170269)
23. Nguyen TL, Sullivan NL, Ebel M, Teague RM, Dipaolo RJ. Antigen-specific TGF-{beta}-induced regulatory T cells secrete chemokines, regulate T cell trafficking, and suppress ongoing autoimmunity. J Immunol. 2011;187(4):1745- 1753.
24. San Juan A, et al. Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA. Biomacromolecules. 2009;10(11):3074-3080.
25. Mishra PK, Tyagi N, Kumar M, Tyagi SC. MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med. 2009;13(4):778-789.
26. Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol. 2007;36(3):184-204. (Pubitemid 350135911)
27. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol. 1998;72(10):8150-8157.
28. Gray SJ, Samulski RJ. Optimizing gene delivery vectors for the treatment of heart disease. Expert Opin Biol Ther. 2008;8(7):911-922. (Pubitemid 352007003)
29. Azuma J, Asagami T, Dalman R, Tsao PS. Creation of murine experimental abdominal aortic aneurysms with elastase. J Vis Exp. 2009;29(pii): 1280.
30. Goergen CJ, et al. Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms. Arterioscler Thromb Vasc Biol. 2011;31(2):270-279.
31. Azuma J, Maegdefessel L, Kitagawa T, Dalman RL, McConnell MV, Tsao PS. Assessment of elastase-induced murine abdominal aortic aneurysms: comparison of ultrasound imaging with in situ video microscopy. J Biomed Biotechnol. 2011;2011:252141.
32. Zhang J, et al. Molecular imaging of activated matrix metalloproteinases in vascular remodeling. Circulation. 2008;118(19):1953-1960.